Dr Mary-margaret James, MD | |
170 Medical Park Rd, Suite 102a, Mooresville, NC 28117 | |
(704) 663-5240 | |
(704) 663-5399 |
Full Name | Dr Mary-margaret James |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 170 Medical Park Rd, Mooresville, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437269644 | NPI | - | NPPES |
891264F | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 200000473 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mary-margaret James, MD 170 Medical Park Rd, Suite 102a, Mooresville, NC 28117 Ph: (704) 663-5240 | Dr Mary-margaret James, MD 170 Medical Park Rd, Suite 102a, Mooresville, NC 28117 Ph: (704) 663-5240 |
News Archive
In the current situation when the fear of virus infections in the public is common, it is good to remember that some viruses can be extremely beneficial for mankind, even save lives. Such viruses, phages, infect bacteria.
After three years of preparing small practices and safety net hospitals in rural Florida to participate in a regional health information exchange (HIE), the not-for-profit CommunityHealth IT has partnered with RelayHealth to enable the transfer of health information among providers and to empower patients and businesses with patient engagement tools.
The American Society of Nephrology (ASN) supports the recommendations, which include advising Americans to reduce their daily salt intake. The recommendations encourage nearly half of Americans to drastically reduce their salt intake.
A Yale Cancer Center clinical trial combining the immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as preoperative treatment for early stage triple negative breast cancer disclosed a 71% pathologic complete response to the combination treatment in the initial phase I trial.
Imagine cutting down the growth of cancer cells at their earliest stages to halt tumor growth. Research conducted by leading cancer metabolism researchers at Stony Brook University, Paul M. Bingham, PhD, and Zuzana Zachar, PhD, is showing promise in this approach with their clinical investigation of a new class of compounds that disrupt cancer cell mitochondrial metabolism.
› Verified 3 days ago
Laura Therese Recchi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 136 Gateway Blvd Ste A, Mooresville, NC 28117 Phone: 704-799-2878 Fax: 704-799-1627 | |
Elizabeth Ellen Tilt, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 136 Gateway Blvd Ste A, Mooresville, NC 28117 Phone: 704-799-2878 Fax: 704-799-1627 | |
Gianna Demos Madrid, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 656 Carpenter Ave, Mooresville, NC 28115 Phone: 704-664-5133 Fax: 704-799-6356 | |
Dr. Stephen James Malloney, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 134 Medical Park Rd Ste 100, Mooresville, NC 28117 Phone: 704-662-0106 Fax: 808-290-6369 | |
Shelley H. Rinker, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 133 Welton Way, Suite C, Mooresville, NC 28117 Phone: 704-664-2552 Fax: 704-664-5382 | |
Lisa Schroepfer Thomas, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 136 Gateway Blvd Ste A, Mooresville, NC 28117 Phone: 704-799-2878 Fax: 704-799-1627 | |
Amy Poteat Ferguson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 656 Carpenter Ave, Mooresville, NC 28115 Phone: 704-664-5133 |